Search for: "Ana Santos Rutschman"
Results 21 - 40
of 52
Sort by Relevance
|
Sort by Date
4 Mar 2021, 10:50 am
Professor Ana Santos Rutschman lists “outbreak unpredictability, pathogen mutation, and disease complexity”—“coupled with the fact that outbreak markets have historically emerged in economically challenged areas”—as contributing factors to the lack of private-sector investment in vaccine preparedness for epidemic illnesses. [read post]
26 Feb 2021, 2:00 am
Ana Santos Rutschman (Saint Louis University), Social Media Self-Regulation and the Rise of Vaccine Misinformation; U. of Pa. [read post]
20 Feb 2021, 2:00 am
Ana Santos Rutschman (Saint Louis University), Social Media Self-Regulation and the Rise of Vaccine Misinformation, U. [read post]
18 Feb 2021, 2:00 am
Ana Santos Rutschman (Saint Louis University), Vaccine Clinical Trials and Data Infrastructure, Utah L. [read post]
27 Dec 2020, 9:06 pm
The Regulatory Review is pleased to highlight our top regulatory essays of 2020 authored by a select number of our many expert contributors. [read post]
23 Dec 2020, 6:59 pm
We asked legal scholar Ana Santos Rutschman, who teaches a course on vaccine law at Saint Louis University, to explain the decision and the rights employees and employers have…” What You Should Know About COVID-19 and the ADA, the Rehabilitation Act, and Other EEO Laws [read post]
4 Dec 2020, 11:30 am
This week, David Elkins (Netanya) reviews a recently posted work by Mirit Eyal-Cohen (Alabama) & Ana Santos Rutschman (St. [read post]
1 Dec 2020, 2:00 am
Mirit Eyal-Cohen (University of Alabama), Ana Santos Rutschman (Saint Louis University), Tax Policy and Pharmaceutical Innovation, SSRN: The COVID-19 pandemic has exposed severe underinvestment in sustained research and development (R&D) of vaccines to prevent public health crises. [read post]
21 Nov 2020, 2:00 am
Ana Santos Rutschman (Saint Louis University), Facebookʼs Latest Attempt To Address Vaccine Misinformation — And Why Itʼs Not Enough, Health Affairs Blog (2020): On October 13, 2020 Facebook announced the adoption of a series of measures to promote vaccine trust... [read post]
31 Oct 2020, 2:00 am
Ana Santos Rutschman (Saint Louis University), Intellectual Property as a Determinant of Health, Vanderbilt J. [read post]
26 Oct 2020, 2:00 am
Ana Santos Rutschman (Saint Louis University), Robert Gatter (Saint Louis University), Timothy L. [read post]
24 Oct 2020, 2:00 am
Wiemken (Saint Louis University), Ana Santos Rutschman (Saint Louis University), Robert Gatter (Saint Louis University), The Case for Face Shields: Improving the COVID-19 Public Health Policy Toolkit, St. [read post]
12 Oct 2020, 8:01 pm
Ana Santos Rutschman: The Intellectual Property of COVID-19 (Source: SSRN) Prof. [read post]
12 Oct 2020, 11:52 am
As Professor Ana Santos Rutschman has documented, the military also has played an important role in the efforts to develop Ebola and Zika vaccines. [read post]
7 Oct 2020, 2:00 am
Yaniv Heled (Georgia State University), Ana Santos Rutschman (Saint Louis University), Liza Vertinsky (Emory University), Regulatory Reactivity: FDA and the Response to COVID-19, Food and Drug J. (2021, Forthcoming): Public health-oriented agencies play a critical role to play in pandemic... [read post]
19 Aug 2020, 12:00 am
Ana Santos Rutschman (Saint Louis University), The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation, 64 Wash. [read post]
6 Aug 2020, 9:00 pm
Yaniv Heled (Georgia State University), Ana Santos Rutschman (St. [read post]
5 Aug 2020, 11:43 am
And the few wealthy countries like Canada that are not making substantial COVID-19 vaccine investments face pressure to do so.These investments have led to charges of “vaccine nationalism” in the popular press, although as Professor Ana Santos Rutschman explains, these strategies are not new. [read post]
2 Aug 2020, 9:00 pm
Ana Santos Rutschman (St. [read post]
29 Jul 2020, 9:00 pm
Ana Santos Rutschman (Saint Louis University), Timothy L. [read post]
